Molecular Diagnostics




Leptomeningeal Disease Diagnosed Using CSF Cell-Free DNA
Leptomeningeal disease (LMD) is a devastating complication of solid and liquid systemic and central nervous system malignant neoplasms. LMD, in which cancer metastasizes to the cerebrospinal fluid, occurs in 4% to 15% of cancer patients and is associated with poor survival, with untreated patients dying within four to six weeks. More...26 Aug 2021

Various Serum Vitamin D Biomarkers Compared for Sarcopenia
Sarcopenia is an age-related clinical condition characterized by a gradual and generalized loss of skeletal muscle mass with a decrease in strength and physical capacity. It is considered to be one of the risk factors for adverse events in older people, including delirium, disability, institutionalization, and even death. More...25 Aug 2021
![Image: Two-dimensional structure of lactosylceramide (Lac-Cer). Lac-Cer levels in the circulation could have prognostic value for SLE patients with CVD (Photo courtesy of [U.S] National Library of Medicine) Image: Two-dimensional structure of lactosylceramide (Lac-Cer). Lac-Cer levels in the circulation could have prognostic value for SLE patients with CVD (Photo courtesy of [U.S] National Library of Medicine)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2021-08-23/GMS-067B.jpg)
Sphingolipids Are Prognostic Biomarkers for African American SLE Patients with Cardiovascular Disease
A recent study found that lactosylceramide levels may have a “predictive” value and sphingolipidomics have an added benefit to currently available tools for the early diagnosis and prognosis of African American systemic lupus erythematosus (SLE) patients with cardiovascular disease (CVD). More...23 Aug 2021

CSF biomarkers Compared for Down Syndrome and Inherited Alzheimer’s
Although most people with Down’s syndrome will experience brain changes as they age, not everyone will develop Alzheimer’s disease or another type of dementia. Whilst having Down’s syndrome does put a person at increased risk, estimated at 1 in 3 people in their 50s, and closer to 2 in 3 aged over 60, it is not inevitable for all. More...19 Aug 2021
In Other News
More Complete Genetic Screening Benefits Cardiovascular Disease Patients
A Novel Liquid Biopsy Spectroscopy Method for Early Detection of Brain Tumors
A Circulating Adipokine Is a Possible Biomarker for Severity of Systemic Sclerosis-Associated Interstitial Lung Disease
Lipid Metabolism Affects GBA-Associated Parkinson's Disease
Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes
Early T-Cell Precursor Lymphoblastic Lymphoma Characterized
Insulin Resistance and T2D Associated With Gut Microbial Diversity
Molecular Assays Compared For MRD Detection In B-ALL
Microbiome and Metabolic Features Tied to IBD Treatment Response
Genomic Test Aids in Determining Prostate Cancer Treatment Options
Advanced Sequencing Techniques Determine Cancer Genome Variants in Young Patients
ALDOA and FH4 Antibodies Associated with Cerebrovascular Disease
Highly Sensitive Genetic Test for Glaucoma Developed
Neurofilament Light Chain Levels Increase Accuracy of Neurodegenerative Disease Detection
Thombomodulin Identified as Unique Biomarker for Diagnosing Necrotizing Soft-Tissue Infections
APOE Gene Influences Alzheimer's Symptoms, Biomarkers in Down Syndrome
Preemies' Blood Type Tied to Risk for Necrotizing Enterocolitis
Optical Genome Mapping Enables Constitutional Chromosomal Aberration Detection
Serum Biomarkers Enable Tracing the Progress of COVID-19 Infections
Rectal Colonization by Klebsiella Leads to Different Risks for Bacteremia
Telomerase Reverse Transcriptase Protein Expression Evaluated for Melanomas
Metabolomic Analytical Approach Identifies Multiple Neonatal Errors of Metabolism Disorders
Targeted Locus Amplification Validated for Lymphoma
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.